Digital Health Integration With Pulmonary Rehabilitation on Patients With Chronic Obstructive Lung Disease

NCT ID: NCT06582082

Last Updated: 2024-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-10

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is an interventional study in which 60 COPD patients estimated to enrol according to random allocation and divided into two groups. The study group will receive pulmonary rehabilitation while the control group will stick to pursed lip breathing only.

Pulmonary function (FEV1, FVC, FEV1/FVC), cognitive function by mini mental state examination, physical function by physical tests also, physical activity and sleep by google fit app and vital signs by using different mobile apps. measurements will be evaluated before initiation of the interventions and 12 weeks thereafter.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PURPOSE:

to evaluate the efficacy of Digital Health Integration with pulmonary rehabilitation on ventilatory, cognitive and physical functions in patients with chronic obstructive lung disease.

BACKGROUND:

chronic obstructive pulmonary diseases are conditions characterized by a variable progression. Some individuals experience longer asymptomatic periods while others acute worsening periods and/or exacerbations triggered by symptom multiplication factors. Medications are adjusted to the patients' respiratory function, self-assessment of health and emerging certain physical changes. A more effective treatment may be applied by real-time data registered during the patient's everyday life Effective, safe, accessible, and engaging digital healthcare solutions which are able to be integrated into global healthcare systems may play a role in helping to meet this demand in COPD care needs. Digital interventions are unrestricted by individual practices or healthcare systems and come in a range of forms, including: synchronous applications (apps) which provide real-time video conferencing or telephone calls; asynchronous solutions such as emails, smartphone messages, or notifications; remote monitoring or recording devices, such as traditional telehealth interventions; information providing devices; and modern multi-tooled digital health apps which can facilitate behavioural changes and self-management..

HYPOTHESES:

Digital Health Integration with pulmonary rehabilitation has no effect on ventilatory, cognitive and physical functions in patients with chronic obstructive lung disease.

RESEARCH QUESTION:

Does Digital Health Integration with pulmonary rehabilitation influence ventilatory, cognitive and physical functions in patients with chronic obstructive lung disease?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Lung Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pulmonary rehabilitation

The study group will receive pulmonary rehabilitation

Group Type EXPERIMENTAL

pulmonary rehabilitation

Intervention Type OTHER

The study group will receive pulmonary rehabilitation

lip breathing

the control group will stick to pursed lip breathing only

Group Type ACTIVE_COMPARATOR

pursed lip breathing

Intervention Type OTHER

the control group will stick to pursed lip breathing only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulmonary rehabilitation

The study group will receive pulmonary rehabilitation

Intervention Type OTHER

pursed lip breathing

the control group will stick to pursed lip breathing only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All gender COPD patients
* Age will be 55-65 years.
* Moderate to severe COPD patients
* emphysema on CT scan (HU ≥ - 900)
* There FEV1 will be less than 80% predicted
* Class II obesity (BMI of 35 to \< 40)
* Medically stable
* greater than 10 pack-year smoking history

Exclusion Criteria

* Very severe COPD - Lung cancer
* Lung resection - Lung fibrosis
* Heart failure - Cognitive disorders that affect the device application
* Musculoskeletal or neurological disorders that interfere with exercise program
* requiring invasive or non-invasive positive pressure ventilation
* inability to speak in complete sentences due to breathlessness
* suspected elevated intracranial pressure - hemodynamic instability
* recent facial, oral, or skull surgery
* active hemoptysis (more than two tablespoons of frank blood per day)
* pneumothorax - failure to comply with the research protocol.
* uncontrolled hypertension, or other concomitant respiratory diseases
* participate at any research or pulmonary rehabilitation program during the period of this study.
* imaging changes of lung disease such as occupancy, exudation and interstitial changes on CT scan.
Minimum Eligible Age

50 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

marwa mahmoud elsayed mahmoud

assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marwa Mahmoud, PhD

Role: CONTACT

01156033818

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marwa Mahmoud, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005239

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.